Douglas Tsao
Stock Analyst at H.C. Wainwright
(4.87)
# 348
Out of 5,005 analysts
1156
Total ratings
51.4%
Success rate
22.2%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Reiterated: Buy | $5 → $10 | $4.18 | +139.23% | 48 | Sep 25, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $1,201 | $285.65 | +320.44% | 57 | Sep 24, 2026 | |
| IMVT Immunovant | Reiterated: Buy | $41 | $33.49 | +22.42% | 47 | Sep 23, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $66 | $33.44 | +97.37% | 14 | Sep 23, 2026 | |
| ALKS Alkermes | Reiterated: Hold | $43 | $40.15 | +7.10% | 61 | Sep 21, 2026 | |
| CABA Cabaletta Bio | Reiterated: Buy | $16 | $2.00 | +700.00% | 52 | Sep 21, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | $7 | $1.14 | +514.04% | 79 | Sep 21, 2026 | |
| DARE Daré Bioscience | Reiterated: Buy | $12 | $0.75 | +1,500.00% | 42 | Sep 21, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $120 | $64.92 | +84.84% | 41 | Sep 21, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $74 | $36.72 | +101.53% | 18 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.27 | -24.64% | 24 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $41 → $47 | $36.98 | +27.10% | 48 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $167 → $170 | $142.59 | +19.22% | 80 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.95 | +63.52% | 57 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,202 | $972.25 | +23.63% | 69 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.6918 | +911.85% | 26 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $1.2 | $0.2616 | +358.72% | 10 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $27.33 | +24.41% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.40 | +105.88% | 44 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $20.57 | +6.95% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.39 | +49.67% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $0.5 → $1.6 | $0.6211 | +157.61% | 48 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 103.00 | kr 33.50 | +207.46% | 52 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.59 | +340.25% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $5 | $0.0112 | n/a | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.00001 | n/a | 13 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $11.74 | n/a | 4 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.09 | n/a | 19 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €19.00 → €11.00 | €2.63 | n/a | 7 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $31 → $33 | $35.70 | n/a | 2 | Jul 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $93 → $80 | $15.10 | n/a | 8 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $41.03 | $8.21 | n/a | 17 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $20.50 | n/a | 2 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $71 → $77 | $71.43 | n/a | 6 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $108 → $120 | $175.57 | n/a | 12 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $270.97 | n/a | 3 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $112.89 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $47 → $50 | $18.27 | n/a | 6 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $238.28 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $294.59 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 → $2 | $14.46 | n/a | 5 | Nov 16, 2016 |
Rezolute
Sep 25, 2026
Reiterated: Buy
Price Target: $5 → $10
Current: $4.18
Upside: +139.23%
Praxis Precision Medicines
Sep 24, 2026
Reiterated: Buy
Price Target: $1,201
Current: $285.65
Upside: +320.44%
Immunovant
Sep 23, 2026
Reiterated: Buy
Price Target: $41
Current: $33.49
Upside: +22.42%
Rapport Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $66
Current: $33.44
Upside: +97.37%
Alkermes
Sep 21, 2026
Reiterated: Hold
Price Target: $43
Current: $40.15
Upside: +7.10%
Cabaletta Bio
Sep 21, 2026
Reiterated: Buy
Price Target: $16
Current: $2.00
Upside: +700.00%
Coherus Oncology
Sep 21, 2026
Reiterated: Buy
Price Target: $7
Current: $1.14
Upside: +514.04%
Daré Bioscience
Sep 21, 2026
Reiterated: Buy
Price Target: $12
Current: $0.75
Upside: +1,500.00%
Disc Medicine
Sep 21, 2026
Reiterated: Buy
Price Target: $120
Current: $64.92
Upside: +84.84%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $74
Current: $36.72
Upside: +101.53%
Sep 10, 2026
Reiterated: Hold
Price Target: $10
Current: $13.27
Upside: -24.64%
Sep 9, 2026
Rated: Buy
Price Target: $41 → $47
Current: $36.98
Upside: +27.10%
Sep 1, 2026
Rated: Buy
Price Target: $167 → $170
Current: $142.59
Upside: +19.22%
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $7.95
Upside: +63.52%
Aug 24, 2026
Reiterated: Buy
Price Target: $1,202
Current: $972.25
Upside: +23.63%
Aug 24, 2026
Reiterated: Buy
Price Target: $7
Current: $0.6918
Upside: +911.85%
Aug 14, 2026
Reiterated: Buy
Price Target: $360 → $1.2
Current: $0.2616
Upside: +358.72%
Aug 10, 2026
Reiterated: Buy
Price Target: $34
Current: $27.33
Upside: +24.41%
Aug 10, 2026
Reiterated: Hold
Price Target: $7
Current: $3.40
Upside: +105.88%
Aug 7, 2026
Reiterated: Buy
Price Target: $22
Current: $20.57
Upside: +6.95%
Aug 5, 2026
Reiterated: Buy
Price Target: $38
Current: $25.39
Upside: +49.67%
Jul 28, 2026
Rated: Hold
Price Target: $0.5 → $1.6
Current: $0.6211
Upside: +157.61%
Jul 24, 2026
Reiterated: Buy
Price Target: kr 103.00
Current: kr 33.50
Upside: +207.46%
Nov 6, 2025
Reiterated: Buy
Price Target: $7
Current: $1.59
Upside: +340.25%
Nov 14, 2024
Downgraded: Hold
Price Target: $125 → $5
Current: $0.0112
Upside: n/a
Aug 21, 2023
Reiterated: Buy
Price Target: $4 → $3
Current: $0.00001
Upside: n/a
Mar 8, 2023
Reiterated: Hold
Price Target: $6
Current: $11.74
Upside: n/a
Nov 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.09
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: €19.00 → €11.00
Current: €2.63
Upside: n/a
Jul 3, 2018
Reiterated: Sell
Price Target: $31 → $33
Current: $35.70
Upside: n/a
Jun 6, 2018
Downgraded: Hold
Price Target: $93 → $80
Current: $15.10
Upside: n/a
Jun 6, 2018
Upgraded: Buy
Price Target: $41.03
Current: $8.21
Upside: n/a
May 1, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $20.50
Upside: n/a
Feb 16, 2018
Reiterated: Hold
Price Target: $71 → $77
Current: $71.43
Upside: n/a
Oct 27, 2017
Reiterated: Hold
Price Target: $108 → $120
Current: $175.57
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $100 → $120
Current: $270.97
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $16
Current: $112.89
Upside: n/a
May 22, 2017
Upgraded: Buy
Price Target: $47 → $50
Current: $18.27
Upside: n/a
Jan 18, 2017
Reiterated: Buy
Price Target: $200
Current: $238.28
Upside: n/a
Nov 30, 2016
Upgraded: Hold
Price Target: n/a
Current: $294.59
Upside: n/a
Nov 16, 2016
Reiterated: Sell
Price Target: $14 → $2
Current: $14.46
Upside: n/a